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ABSTRACT 28 
Objective: To look at the trends in prevalence of generalised (body mass index (BMI) ≥25 29 
kg/m2) and abdominal obesity (waist circumference (WC) >102cm, men; >88cm, women) 30 
among older people from 1993 to 2008, prevalence of chronic disease by overweight/obesity 31 
and waist circumference categories in England 2005 and evaluate the association of these 32 
measures with chronic diseases.  33 
Methods: Analyses of nationally representative cross-sectional population surveys, the 34 
Health Survey for England (HSE), including non-institutionalised men and women aged ≥ 35 
65years. 36 
Results: Generalised obesity and abdominal obesity increased among men and women from 37 
1993 to 2008. In 2005, the HSE 2005 focussed on older people. 72% of men and 68% of 38 
women aged over 65 were either overweight or obese. Prevalence of raised WC was higher in 39 
women (58%) than in men (46%). The prevalence of diabetes and arthritis was higher in 40 
people with generalised obesity in both sexes. Men were more likely to have had a joint 41 
replacement and had a higher prevalence of stroke if they were overweight only but women 42 
were more likely to have had a joint replacement only if they were obese (13%) and had a 43 
higher risk of falls with generalised obesity. The pattern was similar for the prevalence of 44 
chronic diseases by raised waist circumference. Multivariate analysis confirmed that 45 
generalised and abdominal obesity were independently associated with risk of hypertension, 46 
diabetes and arthritis in both men and women. In women only, there was an association 47 
between generalised obesity and having a fall in the last year (OR: 1.5), and between 48 
abdominal obesity and having a joint replacement (OR: 1.9, p=0.01)  49 
Conclusion: Complications of obesity such as diabetes, hypertension and arthritis, are more 50 
common in men and women aged over 65 who are overweight or obese, as well as in those 51 
with a raised waist circumference. These conditions impact on morbidity, mortality and have 52 
cost implications for the health service and are known to improve with weight loss even in old 53 
age. Treatment strategies to address these conditions such as weight management and 54 
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prevention of overweight and obesity are important even in older people. There is a need to 55 
ensure that older people are given appropriate advice about keeping physically active and 56 
eating sensibly. 57 
Keywords: older people, obesity, chronic diseases, population survey 58 
 59 
60 
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INTRODUCTION 61 
The global prevalence of obesity is increasing rapidly in all age groups, including older 62 
people and is a cause for major concern.1 The World Health Organisation has described the 63 
situation as an epidemic and estimates that 1 billion adults worldwide are overweight, of 64 
whom at least 300 million are obese.2 Obesity is an important public health burden among 65 
older people due its association with poor health and well-being,3 reduced life expectancy, 4  66 
and premature death5 due to associated co-morbidities such as cardiovascular disease (CVD), 67 
diabetes, hypertension and stroke, and certain forms of cancer.6  The literature shows quite 68 
conflicting associations between obesity and mortality.7 8 A systematic review9 showed the 69 
overall association between BMI and all-cause mortality in people over 65 as a flat-bottomed 70 
U-shape curve, with increased mortality in those with BMI above 30-31 kg/m2.  It has also 71 
been suggested that as associations of BMI with mortality are at least in part due to 72 
confounding factors such as physical activity, diet, body composition or fat distribution so it 73 
is difficult to isolate the causal effects.10 11 74 
 75 
With ageing there are changes in body composition (sarcopaenia): the age-related loss of 76 
muscle mass and increase in fat mass12 that results in little change in BMI. There is also a 77 
change in distribution of fat with age, an increase in abdominal fat in relation to skeletal or 78 
total body fat.48 It is generally recognised that the central deposition of fat (abdominal or 79 
visceral obesity) is more closely associated with obesity-related chronic diseases13 14and 80 
quality of life.15 Waist circumference measurements are considered important, in the absence 81 
of body composition data. The International Obesity Task Force (IOTF)16 has emphasised that 82 
the health burden of obesity would be more easily predicted if the hazards of accumulating 83 
intra-abdominal fat were also monitored, in addition to BMI, by measuring waist 84 
circumference (WC).  85 
 86 
The aims of this paper are to look at the trends in the prevalence of overweight and obesity 87 
(body mass index (BMI) ≥25 kg/m2 and ≥30kg/m2) and abdominal obesity (WC) >102cm, 88 
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men; >88cm, women) among older people from 1993 to 2008, look at prevalence of chronic 89 
disease by generalised and abdominal obesity and evaluate the association of these measures 90 
with chronic diseases in England 2005.  91 
 92 
METHODS 93 
The HSE is a continuous series of large, cross-sectional annual surveys in a representative 94 
sample of the non-institutionalised English population designed to provide health related 95 
information on the general population in England. From 1991 to 2004, it was commissioned 96 
by the English Department of Health, and since 2005 by the NHS Information Centre. The 97 
survey has a series of core elements that are included every year and special topics that are 98 
included in selected years. The annual household response rate for adults varied between 76% 99 
(1993) and 68% (2008), depending on the survey year. The trends data is presented for people 100 
aged ≥65 with valid height, weight and waist circumference data from the annual surveys 101 
over the period 1993 to 2008.17 A majority of the sample (~94%) in each of these years was of 102 
self-defined ‘white’ ethnic group. The main focus of this paper is on chronic disease among 103 
older people. In 2005, the Health Survey for England (HSE) included an additional, nationally 104 
representative general population sample of English people aged 65 and over, living in private 105 
households. Like previous surveys in the HSE series, the 2005 survey adopted a multi-stage 106 
stratified probability sampling design using the English Postcode Address File (PAF) as the 107 
primary sampling frame. It comprised a core (general population) sample randomly selected 108 
using 7,200 addresses in 720 postcode sectors, and a boost sample of people aged 65 and 109 
over, selected using 11,520 additional addresses at the same 720 postcode sectors as the core 110 
sample. Households were screened to identify whether older people were resident and, in 111 
these cases, interviews and nurse visits were conducted. The total sample aged 65 and over 112 
who were interviewed included 4,269 residents (723 men, 873 women in the general 113 
population sample and 1,174 men and 1,499 women in the boost sample). The overall 114 
response rate among men and women aged 65 and over was 71% in the general population 115 
sample and 74% in the boost sample. The sampling design and methodology have been 116 
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described in more detail elsewhere.18 Ethical approval for the survey was obtained from the 117 
North Thames Multi-centre Research Ethics Committee (MREC) and from relevant Local 118 
Research Ethics Committees (LRECs) in England.  119 
 120 
Measurements 121 
Interviewers collected data from participants by computer-aided personal interview (CAPI) on 122 
socio-demographic aspects (including age, sex,  and region), health behaviours (including 123 
questions about general self-reported health, smoking etc) and doctor diagnosed health 124 
conditions (ischaemic heart disease, stroke and diabetes). Height and weight measurements 125 
were taken in light clothing without shoes. Height was measured using a portable stadiometer 126 
with a sliding head plate, a base plate and three connecting rods marked with a metric 127 
measuring scale with participants stretching to the maximum height and the head positioned 128 
in the Frankfort plane.  The reading was recorded to the nearest millimetre.  Weight was 129 
measured using Soehnle, Seca or Tanita electronic scales with a digital display. Informants 130 
were asked to remove shoes and any bulky clothing. The reading was recorded to the nearest 131 
100g. Informants who were chairbound, or unsteady on their feet were not weighed. Height 132 
and weight measurement were used to calculate body mass index (BMI, the weight in 133 
kilograms divided by the square of the height in metres).  134 
 135 
After the interviewer visit, those who agreed had a nurse visit. Nurses collected information 136 
including current medication and vitamin supplement usage; and took measurements such as 137 
WC and blood pressure (as well as other physical measurements) using standardised 138 
procedures.19 Waist circumference was defined as the midpoint between the lower rib and the 139 
upper margin of the iliac crest. WC was defined as the midpoint between the lower rib and the 140 
upper margin of the iliac crest. It was measured using a tape with an insertion buckle at one 141 
end. The measurement was taken twice, using the same tape, and was recorded to the nearest 142 
even millimetre. Those whose two WC differed by more than 3 cm had a third measurement 143 
taken. The mean of the two valid measurements was used in the analysis. Informants with 144 
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measurements considered unreliable by the nurse, for example due to excessive clothing or 145 
movement, were excluded from the analysis. The definition of raised WC was, in accordance 146 
with the ATP (Adult Treatment Panel) III,20 >102cm in men and >88cm in women.  147 
 148 
Valid height measurements were obtained from 81% of men and 76% of women; valid weight 149 
measurements were obtained from 84% of men and 80% of women interviewed. Weight and 150 
height measurements allowed BMI to be computed for 79% of men and 73% of women. Valid 151 
waist measurements were obtained for 96% of men and 95% of women who were visited by a 152 
nurse. 153 
 154 
In this paper reference to generalised obesity is for  BMI ≥25 kg/m2 and abdominal obesity is 155 
defined as WC >102cm in men and >88cm in women. 156 
 157 
Statistical analysis  158 
Analysis was carried out using SPSS v15 and STATA v10.0. Informants with missing 159 
information were excluded from analysis. In 2003, non-response weighting was introduced 160 
for the first time in the HSE series. Trend data presented in Figures 1 and 2 before 2003 is not 161 
weighted for non-response. Data for other analyses were weighted appropriately to take into 162 
account non-response and to correct for unequal sample selection. Data on prevalence of 163 
chronic diseases by overweight/obesity and raised WC was age- standardised to the mid-2000 164 
population estimates and the Chi square test was used to test differences in prevalence of 165 
disease by BMI or raised waist circumference. To further investigate the link between 166 
different fat patterns and risk of chronic disease, sex-specific logistic regression models were 167 
developed. The dependant variables in the two models were BMI ≥ 25 kg/m2 and WC >102cm 168 
in men and >88cm in women which were run separately, adjusted simultaneously by the 169 
independent variables included in the models. These were age group, smoking status, region, 170 
social class, general health, longstanding illness, hypertension, self reported chronic 171 
conditions (such as heart disease, stroke, diabetes, cancer, arthritis, osteoporosis, joint 172 
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replacement, chronic lung disease) and reporting having a fall in the last year. The analysis 173 
was run in STATA to enable statistical adjustment for the complex (clustered and stratified) 174 
survey design. 175 
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RESULTS 176 
Tables 1 presents participants’ characteristics. Figure 1 shows the trends in overweight 177 
including obesity (BMI ≥ 25 kg/m2) and obesity (≥ 30 kg/m2) using three year moving 178 
averages to smooth out any unusually high or low values in individual years. The prevalence 179 
of obesity increased among men aged 65-74 from 15.4% in 1993 to 34.6% in 2008 (p<0.001) 180 
and for overweight including obesity from 69.4% to 82.9 %( p<0.001). In men aged ≥75 181 
obesity increased from 10.8% in 1993 to 23.1% in 2008(p<0.001) and prevalence of 182 
overweight including obesity increased from 57.1% to 72.1 %( p<0.001). In women aged 65-183 
74, prevalence of obesity increased from 22.8% in 1993 to 36.8% in 2008(p<0.001) and 184 
prevalence of overweight including obesity from 62.9% to 71.8 %( p<0.001). In women 185 
aged≥75, prevalence of obesity increased from 16.7% to 26.9% (p<0.001) and prevalence of 186 
overweight, including obesity increased from 58.0% to 65.7% (p<0.001). It is important to 187 
note that there were some fluctuations between these years. Abdominal obesity also increased 188 
in both men and women from 1993 to 2008, but again with fluctuations between the years 189 
(Figure 2).  190 
Prevalence of overweight, obesity and raised waist circumference, by age and sex 191 
72% of men and 68% of women were either overweight (BMI ≥ 25-30 kg/m2) or obese (BMI 192 
≥ 30 kg/m2).A greater proportion of men than women were overweight (47% vs 39%, 193 
p<0.0001) but a greater proportion of women (28%) than men (24%) were obese (Table 1). 194 
 195 
The proportion with a raised WC (was higher in women (58%) than in men (46%) overall and 196 
in all age groups (p<0.0001). The largest difference between the sexes was in those aged 80-197 
84 (60% of women, 40% of men, p<0.0001) (Table 1).  198 
 199 
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Prevalence of chronic diseases by BMI categories: overweight including obesity and 200 
obesity 201 
Age standardised prevalence of diabetes was significantly higher in overweight including 202 
obese participants of both sexes in comparison with those who were of desirable weight or 203 
underweight (13% vs 7%, p=0.001 in men, 11% and 5%, p<0.0001 in women). Similar 204 
findings are also found for those in the obese category compared with those not obese (16% 205 
vs 10%, p=0.002 and 16% and 6%, p<0.0001, respectively). 206 
 207 
The prevalence of arthritis was higher in overweight or obese people of both sexes in 208 
comparison with those categorised as of desirable weight or underweight in men (34% vs 209 
23%, p<0.0001) and in women (48% vs 35%, p<0.0001). This was also true for obese men 210 
(39% of obese men vs 29%, not obese, p<0.0001) and women (52% vs 40%, p<0.0001, 211 
respectively).  212 
 213 
Men were more likely to have had a joint replacement if they were overweight compared with 214 
those that were not overweight (8% vs 5%, p=0.01), while women were more likely to have 215 
had a joint replacement only if they were obese (13%, compared with those that were not 216 
obese 9%, p=0.01).  Men had a higher prevalence of stroke if they were overweight compared 217 
with those that had an ‘acceptable weight’ (8% vs 5%, p=0.04). 218 
  219 
In women only, the prevalence of falls was greater in those overweight including obese in 220 
comparison with those of desirable weight or less (29% and 23%, p=0.009, Table 2).  221 
 222 
Prevalence of chronic diseases by raised WC  223 
The pattern for the prevalence of chronic diseases by raised WC was very similar to that 224 
shown by overweight including obesity and obesity. The prevalence of diabetes and arthritis 225 
was higher in those with a WC in comparison with those with an ‘acceptable’ WC. Joint 226 
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replacements were more likely among both men and women with a raised WC compared with 227 
those with an ‘acceptable’ WC measurement (Table 3).  228 
 229 
Due to these differences shown above, it was important to carry out the multivariate analysis 230 
to look at risk of chronic conditions separately for men and women and for generalised and 231 
abdominal obesity.  232 
 233 
Multivariate regression analysis, adjusted simultaneously by the independent variables 234 
included in the models showed that for both sexes, generalised  obesity declined by age group 235 
in women from age group 70-74 onwards and in men from age group 75-79 years (reference 236 
group being aged 65-69). The odds of being diabetic, having high blood pressure and arthritis 237 
were higher in people with generalised and abdominal obesity. In men only, those with 238 
generalised obesity had an increased risk of stroke (OR: 1.7, p=0.04). In women only, 239 
generalised obesity was associated with increased the risk of having a fall in the last 12 240 
months (OR: 1.5, p=0.02) and women with abdominal obesity were more likely to have had a 241 
joint replacement (OR: 1.9, p=0.01, Tables 4 and 5). 242 
 243 
244 
  
12
DISCUSSION  245 
This study shows obesity to be a significant problem among older people living in England 246 
2005. This large nationally representative dataset shows that the prevalence of generalised 247 
and abdominal obesity increased among older people from 1993 to 2008, but with fluctuations 248 
in some years.  Obesity represents an increasing problem worldwide.21  A disruption in energy 249 
balance, environmental and social factors have a predominant role in development of 250 
overweight and obesity throughout the life course. 22 Data from another study shows the rapid 251 
rise in obesity in younger adults.23  As the ageing population is increasing and this trend is 252 
likely to continue, 24 both the rise in the obesity epidemic and the increase in the ageing 253 
population predicts an unprecedented demand on social and health care systems that is likely 254 
to increase substantially in the future.25  255 
 256 
The data show a high prevalence of generalised and abdominal obesity in both men and 257 
women. Men had a higher prevalence of being overweight than women but a higher 258 
proportion of women were obese than men. The results are in agreement with another similar 259 
survey.26 Abdominal obesity was more prevalent in women than in men (58% and 46% 260 
respectively). Abdominal obesity in women has been found to be associated with higher 261 
levels of blood pressure and insulin resistance.27   262 
 263 
This is the first investigation in England using data collected in large, nationally 264 
representative samples to look at generalised and abdominal obesity and risk of chronic 265 
conditions in older people. Our data shows that both generalised and abdominal obesity are 266 
associated with increased risks of diabetes, hypertension and arthritis, in both sexes. Obesity 267 
is a well known contributing factor to the development of type 2 diabetes, which itself can 268 
increase the risk of cardiovascular disease and can lead to other complications that can affect 269 
the quality of life. The results of this study are in agreement with other studies providing 270 
evidence of both types of obesity being associated hypertension.28 29 30 271 
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The data shows that arthritis was more common in those with generalised and abdominal 272 
obesity, which has also been shown in other studies.31 32 An effective treatment for severe 273 
arthritis is joint replacement, which is found in the age adjusted prevalence analysis to be as 274 
more likely in people categorised as overweight or with raised waist circumference. 275 
Multivariate analysis, adjusting for other factors shows that joint replacement was common 276 
only in women with abdominal obesity. Another survey has shown that overweight and 277 
obesity as well as raised waist circumference was related to increased prevalence of 278 
cardiovascular disease, diabetes, hypertension and arthritis in men and women.33  It is 279 
surprising that our data does not show any association between abdominal or generalised 280 
adiposity and heart disease. This may be due to the nature of the survey which was cross-281 
sectional. It is evident that overweight/obese individuals and those with diabetes have a higher 282 
incidence of, and also higher mortality from, circulatory diseases34 and are probably less 283 
likely to survive to be included in this survey, compared with overweight and obese 284 
individuals without diabetes.  285 
 286 
This study shows that among men, stroke was associated with generalised obesity but not 287 
with abdominal adiposity. Contrary to the findings in a prospective study that showed 288 
abdominal adiposity to be more closely associated than generalised obesity to stroke,35 289 
although general adiposity may be more important for cardiovascular disease and mortality.36  290 
 291 
Women with generalised obesity are shown to have increased risk of falls, after adjusting for 292 
other factors. Muscle weakness and a poorer sense of balance are more common in those 293 
leading sedentary lives.37 Obesity is therefore an additional indirect risk factor for falls. 294 
Encouraging physical activity, such as by walking or cycling by incorporating it into daily life 295 
could help reduce risk of falls and  also contribute to curbing or reversing the obesity 296 
epidemic. 297 
 298 
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The multivariate analysis shows a steady decline in BMI by age group among people aged 65 299 
and over, seen in both sexes. This is likely to reflect age related changes in body composition 300 
i.e. a decline in lean muscle mass and increase in fat mass, the latter being lighter in weight. 301 
This has also been shown in other studies.38 Longitudinal studies confirm that after 65 years 302 
of age, the rate of weight loss occurs at an average rate of up to 0.65 kg/yr,39 although there is 303 
substantial variation between individuals. Loss of muscle mass begins from 30 to 40 years of 304 
age and continues into advanced old age.40 Ageing also influences the distribution of adipose 305 
tissue. Because fat replaces fat-free mass with increasing age, older people may have a greater 306 
proportion of fat than younger individuals with the same BMI. The change in distribution of 307 
fat with age results in an increase in abdominal fat in relation to total body fat. Thus older 308 
people are more likely to have a raised waist circumference, a risk factor for metabolic 309 
syndrome and other adverse health outcomes35 36 that predicts future risk of chronic 310 
conditions such as type 2 diabetes, morbidity13 and all-cause mortality. The data showed that 311 
abdominal obesity   increased by more than 10% from 1993 to 2008 in both men and women. 312 
These results strongly suggest the need for health care professionals to incorporate waist 313 
circumference measurements in their routine practice for early identification of abdominal 314 
obesity. 315 
 316 
The results show a strong association between both types of obesity with hypertension, 317 
diabetes and arthritis and other chronic conditions.  It is evident that unless there are effective 318 
strategies to slow the increase or reverse the direction of trends in generalised and abdominal 319 
obesity in all groups3 41 there may be a substantial rise in the prevalence of some of these co-320 
morbidities in the future,  increasing the burdens of disability-associated health and social 321 
care costs.42  322 
 323 
There is large body of evidence indicating that weight loss is an effective strategy for 324 
reducing risk for hypertension, diabetes and arthritis and other conditions and can lead to 325 
clinical benefits and improvements in health.43 44 45  46 32 47 Reviews by Villareal et al,48 and 326 
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Zamboni et al,49 have shown that management of obesity is important in older people (aged 327 
≥65) and can improve obesity-related complications. Although a recent systematic review and 328 
meta- analysis showed a lack of high-quality evidence to support the efficacy of weight loss 329 
programmes in obese older people, 50 it is of paramount importance to include strategies to 330 
control obesity and related co-morbidities among older people. Lifestyle modifications that 331 
include increasing physical activity to preserve muscle mass is an important component in 332 
any weight loss or weight management programme for people who are overweight to prevent 333 
them becoming obese.  334 
 335 
Research shows that being overweight can offer some protection for older people, it reduces 336 
the loss of bone mass, and overweight elderly people are less likely to suffer hip fractures, a 337 
major cause of morbidity and mortality.48 However, the range of evidence of health risks of 338 
overweight and obesity are greater than any advantages. 339 
 340 
Limitations of this study are that this is a cross-sectional study; therefore the directionality of 341 
the associations between chronic conditions and adiposity cannot be clearly established. 342 
However, evidence from other epidemiological studies show that obesity predicts chronic 343 
conditions to support our findings. 31 32 33 344 
 345 
The most commonly used anthropometric index of obesity is the BMI. However, BMI has 346 
been questioned in the assessment of older populations as it is not a good indicator of body fat 347 
distribution. There is evidence that measures of abdominal obesity have a more important role 348 
than BMI in physical health outcomes.51  349 
 350 
There is controversy about the best measure in the assessment of abdominal obesity. We used 351 
waist circumference measurements rather than waist-hip ratio (WHR) calculations in 352 
accordance with the ATP III recommendations,20 also in view of the lack of consensus about 353 
appropriate WHR levels and what thresholds should be used to define raised WHR.13 354 
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Measurements of body composition (that are not included in the HSE) are a better indictor  of  355 
fat mass, important  to look further at the link between fat percentage (that increases with 356 
ageing) and risk of chronic disease.  357 
 358 
CONCLUSION 359 
Both generalised and abdominal obesity rates continue to increase among older people in 360 
England. Because of this increase it can be expected that the risk of co-morbidities will also 361 
increase in the future. Our findings have confirmed the high prevalence of chronic diseases 362 
and problems that require healthcare among people aged 65 and over. The consequences of 363 
obesity such as diabetes, hypertension and arthritis improve with weight loss even in old age. 364 
Prevention of obesity is therefore as important as other treatment strategies for chronic 365 
diseases. There is an urgent need for improvement in treatment of obesity through effective 366 
evidence based weight management interventions aimed to include the older population. 367 
 368 
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FIGURE 1: LEGEND 
 
Figure 1: Trends in generalised overweight and obesity (BMI≥ 25 and BMI≥ 30 
kg/m2) in men and women aged 65-74 and 75 and over  
 
FIGURE 2: LEGEND 
 
Figure 2: Trends in abdominal obesity (raised waist circumference: >102cm in 
men and >88cm in women) in men and women aged 65-74 and 75 and over
Table 1 Sample characteristics by sex a 
Characteristics Men Women 
N  Interviewer visit 1897(44%) 2372(56%) 
N  Valid BMI 1512 (46%) 1747(54%) 
N  Nurse visit (valid waist measurement) 1393(46%) 1617(54%) 
Mean (SD) age [y] 73.1 (6.2) 73.7 (6.4) 
Diabetes % CI 
Yes 11 (9.4,12.6 ) 9 (7.7,10.3)
No 89 (87.4, 90.6)  91 (89.7,92.3) 
Hypertension % CI   
No  hypertension 38 (35.6,40.5) 36 (33.8,38.3) 
Hypertensive controlled  18 (16.1, 19.9) 18 (16.2,19.8) 
Hypertensive uncontrolled 18 (16.1,19.9) 22 (20.1,23.9) 
Hypertensive untreated 26 (23.8,28.2)  24 (22.0,26.0) 
Mean BMI ( kg/m2) 27.4 (27.3,27.7) 27.7 (27.5,28.0) 
BMI categories % CI   
20-25 kg/m2 27 (24.8,29.2) 27 (24.9,29.1) 
25-30  kg/m2 47 (44.5,49.5) 39 (36.7,41.3) 
over 30 kg/m2 25 (22.8, 27.2) 29 (26.9,31.3) 
less than 20 kg/m2 2 (1.3,2.7) 5 (4.0,6.0) 
Mean waist circumference (cm)   
Waist circumference (WC) % CI   
‘Normal’ WC 54 (51.5, 56.5) 42 (39.7,44.3) 
Raised WC  
(>102 cm in men, >88 cm in women) 46(43.5, 48.5)  58 (55.7,60.3) 
Cigarette smoking status % CI   
Never smoked  34 (31.6,36.4) 57 (54.7,59.3) 
Ex-smoker  54 (51.5,56.5) 31 (28.8,33.2) 
Current smoker 12 (10.4,13.6) 11 (9.5,12.5) 
Social Class % CI 
Non Manual 48 (45.5,50.5) 57 (54.7,59.3) 
Manual 52 (49.5,54.5) 43(40.7,45.3) 
General Health (%) CI 
Very good/good  61(58.5,63.5) 60 (57.7,62.3) 
Fair 30 (27.7,32.3) 32 (29.8,34.2) 
Bad/very bad 9 (7.6,10.4) 9 (7.7,10.3)
Limiting longstanding Illness (%) CI   
No longstanding illness  32 (29.7,34.4) 32 (29.8,34.2) 
Limiting  longstanding illness  38 (35.6,40.5) 40 (37.7,42.3) 
Non limiting longstanding illness  30 (27.7,32.3) 27 (24.9,29.1) 
Stroke (%) CI   
Absent 93 (91.7,94.3) 95(94.0,96.0) 
Present 7 (5.7,8.3) 55 (4.0,6.0) 
Heart disease (%) CI   
Absent 78 (75.9,80.1) 86 (84.4,87.6) 
Present 22 (19.9,24.1) 14 (12.4,15.6) 
Osteoporosis (%) CI   
Absent 98(97.3,98.7) 89 (87.5,90.5) 
Present 2 (1.3,2.7) 11(9.5,12.5)
Falls in the last 12 months (%) CI   
Absent 80 (78.0,82.0) 74 (71.9,76.1) 
Present 20 (18.0,22.0) 26 (23.9,28.1) 
Arthritis (%) CI   
Absent 69 (66.7,71.3) 57 (54.7,59.3) 
Present 31(28.7,33.3) 43(40.7,45.3) 
Joint replacement (%)   
Absent 91(89.6,92.4) 88(86.5,89.5) 
Present 9 (7.6,10.4) 12(10.5,13.5) 
a For participants providing a valid BMI measurements. See supplementary data Appendix 2 for further information  
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Table 2 Age-standardised prevalence of chronic diseases and falls, by overweight and obesity
  
BMI status (%) All ≤ 25 
kg/m2 
All≥25 
kg/m2 
(overweight 
including 
obese) 
Difference in 
prevalence of 
disease:  
(BMI≤ 25 kg/m2 
and≥ 25 kg/m2) 
Significant (p value, 
95% CI) or NS 
All ≤ 30 kg/m2 All ≥ 30 
kg/m2 
(obese)  
Difference in 
prevalence of 
disease:  
(BMI≤ 30 kg/m2 
and≥ 30 kg/m2) 
Significant (p value, 
95% CI) or NS 
Prevalence of disease % %   %
Mena N=417 N=1093 N=1135 N=375 
IHDa 21 22 NS 22 21 NS 
Stroke 5 8 p=0.04 (0.4,5.6) 7 7 NS 
Diabetes  7 13 p=0.001(2.8,9.2) 10 16 p=0.002(1.9,10.1) 
Falls 22 19 NS 20 21 NS 
Asthma 11 9 NS 9 13 NS 
Chronic lung disease, such as 
chronic bronchitis or 
emphysema 12 7 NS 9 6 NS 
Cancer or a malignant 
tumour (excluding minor 
skin cancers) 10 10 NS 10 9 NS 
Arthritis (including 
osteoarthritis or rheumatism) 23 34 p<0.0001(6.1,15.9) 29 39 p<0.0001(4.4,15.6)
Osteoporosis 2 2 NS 2 1  
Whether ever had joint 
replacement(s) 5 8 p=0.04(0.4,5.6) 7 9 NS 
Any emotional, nervous or 
psychiatric problems 6 4 NS 5 2 NS 
Parkinson’s disease 1 0 NS 1 0 NS 
Womena n=555 n=1189  n=1229 n=515  
IHDa 14 16 NS 13 19 NS 
Stroke 7 5 NS 5 5 NS 
Diabetes (excluding 
pregnant) 5 11 p<0.0001(3.5,8.5) 6 16 p<0.0001(6.6,13.4)
Falls 23 29 p=0.009(1.7,10.3) 26 29 NS 
Asthma 10 13 NS 11 14 NS 
Chronic lung disease, such as 
chronic bronchitis or 
emphysema 6 6 NS 6 7 NS 
Cancer or a malignant 
tumour (excluding minor 
skin cancers) 10 9 NS 9 10 NS 
Arthritis (including 
osteoarthritis or rheumatism) 35 48 p<0.0001(8.1,17.9) 40 52 p<0.0001(6.9,17.1)
Osteoporosis 14 10 NS 12 10  
Whether ever had joint 
replacement(s) 8 12 p=0.01(1.1,6.9) 9 13 p=0.01(0.7,7.3) 
Any emotional, nervous or 
psychiatric problems 6 7 NS 6 8 NS 
Parkinson’s disease 0 0 NS 0 1 NS 
 
aIHD- Ischaemic heart disease, reported as doctor diagnosed angina or heart attack  
a n is unweighted 
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Table 3 Age standardised prevalence of chronic diseases and falls, by raised waist circumference 
(WC) and sex 
Prevalence of disease Raised waist circumference (%) 
 
Men Women 
 N=752 N=641  N=681 N=936  
 % with WC 
(<102 cm) 
% with WC 
(≥102 cm) 
Difference in 
prevalence of 
disease: 
(% with WC (<102 
cm)  and≥ 102 cm)
Significant (p value, 
95% CI) or NS 
% with WC 
(<88 cm) 
% with 
WC (≥88 
cm) 
Difference in 
prevalence of 
disease:  
((% with WC (<88 
cm)  and≥ 88 cm) 
Significant (p value, 
95% CI) or NS 
IHDa 22 23 NS 14 17 NS
Stroke 8 9 NS 6 6 NS
Diabetes 8 17 p<0.0001(5.5,12.5) 4 14 p<0.0001(7.3,12.7)
Falls 21 25 NS 27 30 NS
Asthma 9 11 NS 9 14 NS
Chronic lung disease, such as 
chronic bronchitis or 
emphysema 10 8 NS 6 8 NS
Cancer or a malignant tumour 
(excluding minor skin cancers) 10 10 NS 9 11 NS
Arthritis (including osteoarthritis 
or rheumatism) 27 39 p<0.0001(7.1,16.9) 40 52 p<0.0001(7.1,6.9)
Osteoporosis 2 2 NS 13 13 NS
Whether ever had joint 
replacement(s)  7 11 P=0.009(1.0,7.0) 9 15 p<0.0001(2.9,9.1)
Any emotional, nervous or 
psychiatric problems 5 3 NS 6 8 NS
Parkinson’s disease 1 1 NS 0 1 NS
 
a b IHD- Ischaemic heart disease, reported as doctor diagnosed angina or heart attack 
a N is unweighted 
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Table 4– Estimated Odds Ratio for overweight including obese (BMI ≥25 kg/m2) by chronic condition 
status Among people Aged 65 years and Over Living in Private Households in England 2005 
 
Men Women 
Variables N=1512 Adjusted* odds 
ratio and 95% 
Confidence 
Interval (CI) † 
P 
values 
N=1747 Adjusted* odds 
ratio and 95% 
Confidence 
Interval (CI) † 
P values 
Age     
65-69 510 1  527 1  
70-74 425 0.8 (0.55,1.22) 0.3 487 0.6 (0.44,0.93) 0.02 
75-79 338 0.7 (0.44,1.02) 0.06 365 0.6 (0.39,0.88) 0.01 
80-84 159 0.5 (0.28,0.82) 0.008 239 0.5 (0.34,0.87) 0.01 
85+ 80 0.3(0.17,0.61) 0.001 129 0.4(0.20,0.67) 0.001 
Diabetes     
Not diabetic  1339 1  1588 1  
Diabetic 173 1.9(1.02,3.36) 0.04 159 2.3(1.20,4.45) 0.01 
Hypertensiona       
No hypertension 398 1  447 1  
Hypertensive controlled  187 1.9(1.17,2.98) 0.004 209 1.7(1.08,2.53) 0.02 
Hypertensive 
uncontrolled  185 2.1(1.29,3.36) 0.003 239 1.9(1.27,2.90) 0.002 
Hypertensive untreated 273 0.99(0.68,1.41) 0.95 303 1.6(1.09,2.22) 0.02 
Arthritis       
Absent 1048 1  995 1  
Present  464 1.7(1.23,2.31) 0.001 752 1.5(1.04,2.07) 0.03 
Stroke       
Absent 1401 1  1659 1  
Present  109 1.8(1.03,3.04) 0.04 88 0.8(0.47,1.37) 0.43 
Had a fall in the last 
year  
      
No  1213 1 1292 1  
Yes  299 0.9(0.62,1.32) 0.60 455 1.5(1.05,2.01) 0.02 
* Adjusted by age, cigarette smoking, social class, region, general health, long standing illness (limiting and non-limiting), 
presence of chronic conditions (heart disease, stroke, cancer, diabetes, hypertension, arthritis, chronic lung disease, joint 
replacement, osteoporosis), fall in last year.  
† Odds ratio and CI are weighted to represent the English population 
 a No Hypertension: SBP <140mmHg and DBP <90mmHg and not taking medication prescribed for high blood pressure 
   Hypertensive controlled: SBP <140mmHg and DBP <90mmHg and taking medication prescribed for high blood pressure 
   Hypertensive uncontrolled: SBP ≥ 140mmHg or DBP ≥ 90mmHg and taking medication prescribed for high blood 
pressure 
   Hypertensive untreated:  SBP ≥ 140mmHg or DBP ≥ 90mmHg and not taking medication prescribed for high blood 
pressure 
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Table 5– Estimated Odds Ratio for raised waist circumference (>102 cm for men and >88cm for women)  
by chronic condition status Among people Aged 65 years and Over Living in Private Households in 
England 2005 
 
* Adjusted by age, cigarette smoking, social class, region, general health, long standing illness (limiting and non-limiting), 
presence of chronic conditions (heart disease, stroke, cancer, diabetes, hypertension, arthritis, chronic lung disease, joint 
replacement, osteoporosis), fall in last year.  
† Odds ratio and CI are weighted to represent the English population 
a No Hypertension: SBP <140mmHg and DBP <90mmHg and not taking medication prescribed for high blood pressure 
   Hypertensive controlled: SBP <140mmHg and DBP <90mmHg and taking medication prescribed for high blood pressure 
   Hypertensive uncontrolled: SBP ≥ 140mmHg or DBP ≥ 90mmHg and taking medication prescribed for high blood 
pressure 
   Hypertensive untreated:  SBP ≥ 140mmHg or DBP ≥ 90mmHg and not taking medication prescribed for high blood 
pressure 
Men Women 
Variables N=1
393 
Adjusted odds 
ratio and 95% 
Confidence 
Interval (CI) † 
P 
values 
N=1617 Adjusted* odds 
ratio and 95% 
Confidence 
Interval (CI) † 
P values 
Age        
65-69 464 1  471 1  
70-74 373 0.9 (0.63,1.19) 0.39 436 0.9 (0.63,1.16) 0.32 
75-79 301 0.9 (0.66,1.25) 0.66 329 0.8 (0.57,1.13) 0.22 
80-84 157 0.6 (0.38,0.91) 0.02 237 0.6 (0.45,0.98) 0.04 
85+ 98 0.5 (0.28,0.80) 0.005 144 0.5(0.29,0.74) 0.001 
Diabetes        
Not diabetic  950 1   1  
Diabetic 1120 2.4(1.62,3.63) <0.0001  2.8(1.70,4.76) <0.0001 
Cigarette 
smoking  
      
Never smoked 469 1 946 1  
Ex smoker 765 1.3(0.96,1.63) 0.1 504 1.4(1.07,1.80) 0.01 
Current smoker 159 0.8(0.50,1.26) 0.33 167 0.8(0.52,1.21) 0.52 
Hypertensiona       
No hypertension 449 1  508 1  
Hypertensive 
controlled  214 2.3(1.63,3.29) <0.0001 255 1.6(1.13,2.25) 0.007 
Hypertensive 
uncontrolled  214 2.0(1.43,2.90) <0.0001 304 2.0(1.01,2.09) <0.0001 
Hypertensive 
untreated 312 1.5(1.09,2.04) 0.01 342 1.2(0.90,1.63) 0.90 
Arthritis       
Absent 948 1  867 1  
Present  445 1.6(1.18,2.09) 0.002 750 1.3(0.98,1.61) 0.08 
Joint 
replacement      
 
Absent 1274 1  1425 1  
Present 119 1.3(0.83,2.07) 0.24 190 1.9(1.23,2.80) 0.003 
Figure 1: Trends in overweight and obesity (BMI≥ 25 and BMI≥ 30 kg/m2) in men and women 
aged 65-74 and 75 years and over 
 
 
 
 
 
 
Figure 2: Trends in abdominal obesity (raised waist circumference: >102cm in men and >88cm 
in women) in men and women aged 65 -74 and 75 years and over  
 
 
 
 
 
 
 
  
 
 
 
